<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOG</journal-id><journal-title-group><journal-title>Open Journal of Obstetrics and Gynecology</journal-title></journal-title-group><issn pub-type="epub">2160-8792</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojog.2023.135078</article-id><article-id pub-id-type="publisher-id">OJOG-125398</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Diagnosis Delay and Assessment of the Quality of Life of Patients with Endometriosis Using the Endometriosis Health Profile 5 Questionnaire in a Sub-Saharan Population
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Monzango</surname><given-names>Sibo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mboloko</surname><given-names>Esimo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mputu</surname><given-names>Lobota</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Itewa</surname><given-names>Monka</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kitenge</surname><given-names>Kia Kayembe</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tambola</surname><given-names>Grace</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Samba</surname><given-names>Kevine</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maesheka</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ntanga</surname><given-names>Kabuya</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Amba</surname><given-names>Naomie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maxime</surname><given-names>Fastrez</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Buka</surname><given-names>Ikoko</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ndjukendi</surname><given-names>Ally</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sangana</surname><given-names>Georges</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Barhayiga</surname><given-names>Berthe</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mbanzulu</surname><given-names>Pita</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Longo</surname><given-names>Mbenza</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Clément</surname><given-names>Ferrier</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Emile</surname><given-names>Darai</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib></contrib-group><aff id="aff8"><addr-line>Department of Gynecology and Obstetrics, Tenon Hospital, Sorbonne University, Paris, France</addr-line></aff><aff id="aff6"><addr-line>Department of Anesthesia and Resuscitation, University Clinics of Kinshasa, Faculty of Medicine, Kinshasa, Democratic Republic of the Congo</addr-line></aff><aff id="aff2"><addr-line>Department of Gynecology and Obstetrics, University Clinics of Kinshasa, Faculty of Medicine, Kisangani, Democratic Republic of the Congo</addr-line></aff><aff id="aff1"><addr-line>Department of Gynecology, Service of Laparoscopic Surgery, Onyx Medical Center, Kisangani, Democratic Republic of the Con-go</addr-line></aff><aff id="aff4"><addr-line>Department of Psychiatry, Neuro-Psychopathological Center of Kinshasa, Faculty of Medicine, Kinshasa, Democratic Republic of the Congo</addr-line></aff><aff id="aff3"><addr-line>3Department of Gynecology and Obstetrics, Erasme Endometriosis Clinic, Free University of Brussels, Brussels, Kingdom of Belgium</addr-line></aff><aff id="aff5"><addr-line>Department of Surgery, Department of Laparoscopic Visceral Surgery, HJ Hospital, Kinshasa, Democratic Republic of the Congo</addr-line></aff><aff id="aff7"><addr-line>Department of Internal Medicine, University Clinics of Kinshasa, Faculty of Medicine, Kinshasa, Democratic Republic of the Congo</addr-line></aff><pub-date pub-type="epub"><day>24</day><month>05</month><year>2023</year></pub-date><volume>13</volume><issue>05</issue><fpage>907</fpage><lpage>917</lpage><history><date date-type="received"><day>24,</day>	<month>April</month>	<year>2023</year></date><date date-type="rev-recd"><day>28,</day>	<month>May</month>	<year>2023</year>	</date><date date-type="accepted"><day>31,</day>	<month>May</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Context: 
  Endometriosis is a pathology that directly affects the daily lives of women with frequent impairment of their quality of life. In our environment, medical, socio-cultural, financial factors and factors related to the organization of the health care system greatly delay its diagnosis. The objectives of the present study were to determine the diagnosis delay and to assess the quality of life before surgery of women with endometriosis using the specific Endometriosis Health Profile 5 (EHP-5) questionnaire. <b>Methods: </b>We carried out a descriptive, observational, retrospective study in 8 medical centers in the City of Kinshasa, from January 2019 to October 2022. A total of 80 women with endometriosis confirmed by laparoscopy (16 diagnostic and 64 operative laparoscopies) and histopathology were interviewed. We used the revised American Society for Reproductive Medicine (rASMR) classification, the Endometriosis Fertility Index (EFI) score was calculated for infertile women and the EHP-5 questionnaire to assess quality of life. Our data was entered and analyzed using Statistical Analysis Software 16.1 (STATA 16.1). <b>Results: </b>Diagnosis delay of endometriosis was on average 12 &#177; 4.3 years. The overall mean EHP-5 score of all patients showed a severe deterioration in quality of life (604 &#177; 235). A negative relationship was observed between the age of the patient, the diagnostic delay, and the alteration of the quality of life in patients over 36 years old and those with about 11 years of diagnostic delay presenting the slight alteration. Patients with a high social level had very severe quality impairment. Women on hormonal treatment, those with a history of pregnancy, childbirth, miscarriage and abortion had a slight and significant deterioration in quality of life (p
   
  &lt;
   
  0.05). <b>Conclusion: </b>Despite some limitations, our preliminary study highlights that in sub-Saharan Africa, the diagnosis of endometriosis is delayed and associated with a severe alteration in quality of life. Moreover, diagnosis of endometriosis seems to be restricted to women with high social levels. Therefore, further efforts are required to develop a health policy to decrease delay for diagnosis with potential benefits on symptoms, quality of life, fertility while limiting stigma and psychological effects of this debilitating pathology.
 
</p></abstract><kwd-group><kwd>Diagnosis Delay</kwd><kwd> EHP-5</kwd><kwd> Endometriosis</kwd><kwd> Quality of Life</kwd><kwd> Sub-Saharan</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Endometriosis is thought to affect 190 million women worldwide [<xref ref-type="bibr" rid="scirp.125398-ref1">1</xref>] with an incidence of 2% to 10% of women of childbearing age [<xref ref-type="bibr" rid="scirp.125398-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.125398-ref2">2</xref>] . This incidence reaches 12% to 45% in infertile women [<xref ref-type="bibr" rid="scirp.125398-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.125398-ref7">7</xref>] . However, it should be emphasized that these epidemiological data emanate from developed countries benefiting easily from advanced imaging modalities (transvaginal ultrasound and MRI) [<xref ref-type="bibr" rid="scirp.125398-ref8">8</xref>] - [<xref ref-type="bibr" rid="scirp.125398-ref12">12</xref>] . Conversely, in sub-Saharan countries, diagnostic tools for endometriosis are more limited thus explaining the insufficient epidemiological data, especially on diagnostic delay, impact on quality of life and fertility management [<xref ref-type="bibr" rid="scirp.125398-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.125398-ref9">9</xref>] - [<xref ref-type="bibr" rid="scirp.125398-ref13">13</xref>] .</p><p>A recent study suggests the contribution of specific questionnaires to assess the diagnosis of endometriosis, ESHRE guidelines underline their limited value [<xref ref-type="bibr" rid="scirp.125398-ref4">4</xref>] . Moreover, due to limited availability of imaging techniques in developing countries, the diagnosis of endometriosis is still made during surgery for pain and/or infertility in women with advanced stages and severe alteration of quality of life (QOL). In this specific setting, previous studies have reported the contribution of non-specific (SF-36) and specific endometriosis questionnaires (EHP-30 and EHP-5) to assess QoL [<xref ref-type="bibr" rid="scirp.125398-ref14">14</xref>] - [<xref ref-type="bibr" rid="scirp.125398-ref18">18</xref>] .</p><p>Therefore, the objectives of the current preliminary study were to determine, in a sub-Saharan population, the time to diagnosis and the evaluation of the quality of life using the EHP-5 questionnaire in women with endometriosis proven by surgery and histology.</p></sec><sec id="s2"><title>2. Material and Methods</title><sec id="s2_1"><title>2.1. Selection of Participant</title><p>We carried out a descriptive, observational, and retrospective study in 8 medical centers in the City of Kinshasa (CPUA, OMC, CUK, Edith Medical, HJ Hospital, Clinique Diamant, Clinique M&#233;decin de Nuit and Clinique Dr. Lipombi); from January 2019 to October 2022 including 80 women with endometriosis confirmed by laparoscopy and histology were interviewed.</p><p>All the women completed symptom questionnaires on gynecological (dysmenorrhea, non-menstrual pelvic pain and dyspareunia), digestive (diarrhea and/or constipation, pain on bowel movement, intestinal cramping, pain on defecation, tenesmus and cyclic rectal bleeding) and non-specific symptoms (lower back pain and asthenia), epidemiological characteristics as well as prior medical treatment and surgery.</p><p>All the women completed the EHP-5 composed of 11 questions. First five questions address pain, control and helplessness, emotional well-being, social support, and self-image. The remaining six questions evaluate the impact on work, relationships with children, sexual relationships, and feelings about the medical profession, treatment, and infertility. Patients are asked to answer questions and rate their quality of life based on the past four weeks.</p><p>Each question is rated on a scale of 5 (never = 1; rarely = 2; sometimes = 3; often = 4; always 5). The score was calculated by summing the responses to the eleven questions: never = 0 points; rarely = 25 points; sometimes = 50 points; often = 75 points; always = 100 points. The scores can therefore range from 0 to 1100. The quality of life is perfect (score = 0), slight deterioration (0 &lt; score ≤ 275), moderate deterioration (275 &lt; score ≤ 550), severe deterioration (550 &lt; score ≤ 825) and very severe alteration (825 &lt; score ≤ 1100). The validated short version of EHP-5 questionnaire was used. The validated French version of the Endometriosis Health Profile-5 or EHP-5 corresponds to a short adaptation of the EHP-30. [<xref ref-type="bibr" rid="scirp.125398-ref17">17</xref>]</p><p>All patients were operated on by laparoscopy, including 16 diagnostic laparoscopies and 64 operative laparoscopies. Briefly, the laparoscopy was performed in the modified dorsolithotomy position under endotracheal general anesthesia. Prophylactic antibiotic therapy was given at the beginning of the operation except for diagnostic laparoscopy. After pneumoperitoneum induction, an umbilical 10 mm trocar was inserted for endoscope and two or three suprapubic 5 mm trocars. After exploration of the abdomino-pelvic cavity and adhesiolysis and resection of endometriotic lesions when required, the extent of the disease was evaluated using the rASMR classification to stage the disease and the EFI score to evaluate the chance of spontaneous pregnancy after surgery. Histological criteria for endometriosis diagnosis included the presence of ectopic endometrial and stromal tissues.</p><p>We considered at a high socio-economic level any patient who fully supported these treatment costs and at a low socio-economic level any patient who was unable to support herself and whose support was provided by social assistance</p></sec><sec id="s2_2"><title>2.2. Ethics Approval</title><p>The study was approved by the Ethics Committee of the School of Public Health of the University of Kinshasa according to the Declaration of Helsinki under number ESP/CE/187/2022. All patients signed informed consent.</p></sec><sec id="s2_3"><title>2.3. Statistical Analysis</title><p>Continuous variables were compared with Student’s t-test and categorical variables were compared with the χ<sup>2</sup> test or Fisher’s exact test, as appropriate. P values &lt; 0.05 were considered statistically significant. STATA software (version 16.1) was used for data analysis.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Epidemiological and Socio-Economic Characteristics of the Population</title><p>The mean patients’ age was 33 &#177; 6.9 years (ranges: 20 to 47 years), and the mean BMI was 21.2 &#177; 4.04 Kg/m<sup>2</sup>. More than three-quarters of the population had university levels, 78% had a university level, 85% of the patients had a high economic level. One-quarter of the population had sport activity with an average of 5.8 hours per week. Forty-one percent of our patients consumed an average of 196 cubic centimeters of alcohol per day (mostly ethanol) and smoking was observed in 16% of the population. History of depression, pregnancy, abdominal surgery and family history of first-degree dysmenorrhea accounted for 13%, 68%, 59% and 24% respectively. In our series, 50% consulted for a desire to conceive.</p></sec><sec id="s3_2"><title>3.2. Symptoms and Pre-Operative Examinations of the Population</title><p>The average diagnostic delay was 11.8 &#177; 4.8 years. The main frequent symptoms suggestive of endometriosis were dysmenorrhea (81%), chronic pelvic pain (70%), deep dyspareunia (64%) and infertility (50%). Although half of the patients had infertility, 68% of the population had a history of pregnancy. Moreover, about half of the patients had a history of abortion. It is interesting to note that one-third of the patients had normal clinical examinations. Only two-thirds of the patients underwent a transvaginal sonography while MRI was performed in 71% of the patients allowing the diagnosis of endometriosis in 91% of them. The clinical and paraclinical characteristics are listed in <xref ref-type="table" rid="table1">Table 1</xref>.</p></sec><sec id="s3_3"><title>3.3. Surgical Characteristics, rASMR Stages and EFI Score of the Population</title><p>All the patients underwent a laparoscopy including 80% operative and 20% diagnostic laparoscopy. The diagnosis of endometriosis was confirmed histologically</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Clinical and paraclinical characteristics</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Population (n = 80)</th></tr></thead><tr><td align="center" valign="middle" >Duration of complaint (year &#177; sd)</td><td align="center" valign="middle" >11.8 (&#177;4.3)</td></tr><tr><td align="center" valign="middle" >Age at first menstruation (year &#177; sd)</td><td align="center" valign="middle" >10.8 (&#177;1.6)</td></tr><tr><td align="center" valign="middle" >Clinical manifestations &#183; Dysmenorrhea &#183; Deep dyspareunia &#183; Dyschesia &#183; Dysuria &#183; Pelvic pain &#183; Metrorrhagia &#183; Infertility</td><td align="center" valign="middle" >81% 64% 38% 23% 70% 49% 50%</td></tr><tr><td align="center" valign="middle" >Presence of endometriosis On clinical examination &#183; Normal &#183; Adnexal mass &#183; Deep pelvic endometriosis &#183; Adnexal mass and Deep pelvic endometriosis On Transvaginal ultrasonography &#183; Normal &#183; Endometrioma &#183; Deep pelvic endometriosis &#183; Adnexal mass and Deep pelvic endometriosis</td><td align="center" valign="middle" >36% 34% 11% 19% 21% 38% 18% 23%</td></tr><tr><td align="center" valign="middle" >Endometriosis on MRI &#183; Not done &#183; Normal &#183; Superficial peritoneal endometriosis &#183; Endometrioma &#183; Deep pelvic endometriosis &#183; Endometrioma and deep pelvic endometriosis</td><td align="center" valign="middle" >29% 4% 11% 28% 16% 12%</td></tr><tr><td align="center" valign="middle" >Ongoing treatment &#183; Hormonal contraception &#183; Hormonal IUD</td><td align="center" valign="middle" >14% 10%</td></tr></tbody></table></table-wrap><p>in all the patients.</p><p>Most of the population had a stage III-IV rASRM stages. EFI score was evaluated for the 40 patients wishing to conceive. The majority of our patients had an EFI score between 4 and 6. These results can be found in <xref ref-type="table" rid="table2">Table 2</xref>.</p></sec><sec id="s3_4"><title>3.4. Quality of Life (QoL) of the Population Using EHP-5</title><p>Using the EHP-5 questionnaire, the mean QoL score was 604 &#177; 235. The distribution of the patients according to QoL quartile is given in <xref ref-type="table" rid="table3">Table 3</xref>. Relations between epidemiologic, economic and symptoms and EHP-5 score are summarized</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Description of surgical parameters</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Population (n = 80)</th></tr></thead><tr><td align="center" valign="middle" >Type of surgery - Diagnostic laparoscopy - Therapeutic laparoscopy &#183; Electro-coagulation of peritoneal lesion &#183; Salpingectomy &#183; Unilateral ovarian cystectomy &#183; Bilateral ovarian cystectomy &#183; Torus resection &#183; Uterosacral ligament resection &#183; Ureterolysis &#183; Colpectomy &#183; Bowel resection</td><td align="center" valign="middle" >20% 14% 9% 12% 26% 19% 21% 5% 16% 11%</td></tr><tr><td align="center" valign="middle" >rASRM stage &#183; I and II &#183; III and IV</td><td align="center" valign="middle" >38% 62%</td></tr><tr><td align="center" valign="middle" >EFI score (n = 40) &#183; (0 - 3) &#183; (4 - 6) &#183; (7 - 8) &#183; (9 - 10)</td><td align="center" valign="middle" >20.0% 47.5% 22.5% 10.0%</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of the QoL of the population according to EHP-5</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >EHP-5, mean score (&#177;sd)</th><th align="center" valign="middle" >604 (&#177;235)</th></tr></thead><tr><td align="center" valign="middle" >Quality of Life/EHP-5 Score - Perfect (score = 0) - Slight alteration (0 &lt; score ≤ 275) - Moderate alteration (275 &lt; score ≤ 550) - Severe impairment (550 &lt; score ≤ 825) - Very severe alteration (825 &lt; score ≤ 1100)</td><td align="center" valign="middle" >0 11% (n = 9) 34% (n = 27) 37% (n = 30) 18% (n = 14)</td></tr></tbody></table></table-wrap><p>in <xref ref-type="table" rid="table4">Table 4</xref>. A negative relationship was observed between the age of the patient, the diagnostic delay and the deterioration of the quality of life in patients over 36 years old and those with about 11 years of diagnostic delay presenting the slight alteration. Patients with a high social level had very severe QoL impairment. Women on hormonal treatment, those with a history of pregnancy, childbirth, miscarriage and abortion had a slight deterioration in quality of life.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>The present retrospective study was to evaluate epidemiologic, socio-economic, and quality of life of patients with endometriosis in the context of a sub-Saharan country underlining the limits of the health care system.</p><p>Although our population corresponds mainly to women with high economic and educational attainments, it is interesting to note that the delay in diagnosis is well over eleven years although most of the patients exhibited symptoms suggestive of endometriosis such as dysmenorrhea, chronic pelvic pain, deep dyspareunia and infertility. Indeed, our delay in diagnosis of 11 years contrasts with those reported in USA (4.4 years) and between 7 and 9 years in France [<xref ref-type="bibr" rid="scirp.125398-ref14">14</xref>] - [<xref ref-type="bibr" rid="scirp.125398-ref18">18</xref>] .</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Relation between epidemiologic, economic and symptoms and EHP-5 score</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variables</th><th align="center" valign="middle"  colspan="4"  >Alteration quality of life</th><th align="center" valign="middle"  rowspan="2"  >p-value</th></tr></thead><tr><td align="center" valign="middle" >Mild</td><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Very Severe</td></tr><tr><td align="center" valign="middle" >Age</td><td align="center" valign="middle" >36 (6.8)</td><td align="center" valign="middle" >36 (5.6)</td><td align="center" valign="middle" >31 (7.0)</td><td align="center" valign="middle" >31 (6.3)</td><td align="center" valign="middle" >&lt;0.05*</td></tr><tr><td align="center" valign="middle" >Complaint duration</td><td align="center" valign="middle" >10.6 (2.0)</td><td align="center" valign="middle" >13.3 (5.2)</td><td align="center" valign="middle" >12.1 (3.8)</td><td align="center" valign="middle" >9.1 (3.0)</td><td align="center" valign="middle" >&lt;0.05*</td></tr><tr><td align="center" valign="middle" >Married status</td><td align="center" valign="middle" >78%</td><td align="center" valign="middle" >70%</td><td align="center" valign="middle" >50%</td><td align="center" valign="middle" >50%</td><td align="center" valign="middle" >0.24</td></tr><tr><td align="center" valign="middle" >University level</td><td align="center" valign="middle" >89%</td><td align="center" valign="middle" >78%</td><td align="center" valign="middle" >77%</td><td align="center" valign="middle" >71%</td><td align="center" valign="middle" >0.81</td></tr><tr><td align="center" valign="middle" >High social level</td><td align="center" valign="middle" >89%</td><td align="center" valign="middle" >70%</td><td align="center" valign="middle" >90%</td><td align="center" valign="middle" >100%</td><td align="center" valign="middle" >0.05*</td></tr><tr><td align="center" valign="middle" >Sports practice</td><td align="center" valign="middle" >22%</td><td align="center" valign="middle" >26%</td><td align="center" valign="middle" >27%</td><td align="center" valign="middle" >21%</td><td align="center" valign="middle" >0.98</td></tr><tr><td align="center" valign="middle" >Dysmenorrhea</td><td align="center" valign="middle" >67%</td><td align="center" valign="middle" >85%</td><td align="center" valign="middle" >83%</td><td align="center" valign="middle" >79%</td><td align="center" valign="middle" >0.64</td></tr><tr><td align="center" valign="middle" >Dyspareunia</td><td align="center" valign="middle" >56%</td><td align="center" valign="middle" >52%</td><td align="center" valign="middle" >73%</td><td align="center" valign="middle" >71%</td><td align="center" valign="middle" >0.33</td></tr><tr><td align="center" valign="middle" >Dyschesia</td><td align="center" valign="middle" >22%</td><td align="center" valign="middle" >33%</td><td align="center" valign="middle" >43%</td><td align="center" valign="middle" >43%</td><td align="center" valign="middle" >0.64</td></tr><tr><td align="center" valign="middle" >Dysuria</td><td align="center" valign="middle" >22%</td><td align="center" valign="middle" >11%</td><td align="center" valign="middle" >30%</td><td align="center" valign="middle" >29%</td><td align="center" valign="middle" >0.35</td></tr><tr><td align="center" valign="middle" >Pelvic pain</td><td align="center" valign="middle" >67%</td><td align="center" valign="middle" >70%</td><td align="center" valign="middle" >67%</td><td align="center" valign="middle" >79%</td><td align="center" valign="middle" >0.87</td></tr><tr><td align="center" valign="middle" >Metrorrhagia</td><td align="center" valign="middle" >33%</td><td align="center" valign="middle" >52%</td><td align="center" valign="middle" >53%</td><td align="center" valign="middle" >43%</td><td align="center" valign="middle" >0.70</td></tr><tr><td align="center" valign="middle" >Infertility</td><td align="center" valign="middle" >56%</td><td align="center" valign="middle" >44%</td><td align="center" valign="middle" >50%</td><td align="center" valign="middle" >57%</td><td align="center" valign="middle" >0.87</td></tr><tr><td align="center" valign="middle" >Hormonal treatment</td><td align="center" valign="middle" >67%</td><td align="center" valign="middle" >56%</td><td align="center" valign="middle" >10%</td><td align="center" valign="middle" >7%</td><td align="center" valign="middle" >&lt;0.05*</td></tr><tr><td align="center" valign="middle" >Pregnancy history</td><td align="center" valign="middle" >100%</td><td align="center" valign="middle" >93%</td><td align="center" valign="middle" >53%</td><td align="center" valign="middle" >29%</td><td align="center" valign="middle" >&lt;0.05*</td></tr><tr><td align="center" valign="middle" >History of childbirth</td><td align="center" valign="middle" >100%</td><td align="center" valign="middle" >93%</td><td align="center" valign="middle" >53%</td><td align="center" valign="middle" >29%</td><td align="center" valign="middle" >&lt;0.05*</td></tr><tr><td align="center" valign="middle" >History of miscarriage</td><td align="center" valign="middle" >22%</td><td align="center" valign="middle" >37%</td><td align="center" valign="middle" >7%</td><td align="center" valign="middle" >7%</td><td align="center" valign="middle" >&lt;0.05*</td></tr><tr><td align="center" valign="middle" >Abortion history</td><td align="center" valign="middle" >56%</td><td align="center" valign="middle" >56%</td><td align="center" valign="middle" >47%</td><td align="center" valign="middle" >29%</td><td align="center" valign="middle" >0.40</td></tr></tbody></table></table-wrap><p>This apparent discrepancy can be explained by the fact that no abnormality at clinical examination was observed in one-third of the patients in our study. Moreover, even after transvaginal sonography, the diagnosis of endometriosis was considered in only two-thirds of the patient. All these data suggest that practitioners are insufficiently aware of the disease thus efforts must be made to improve not only medical awareness but also socio-cultural and financial factors in the health care system in our environment contributing to delayed diagnosis, Also, the availability of a new test based on the expression of miRNAs in the saliva of endometriosis patients could be a good option to overcome the diagnosis delay of endometriosis but raises the issue of its cost especially in developing countries.</p><p>The normalization of pain by patients and by professionals during menstruation and/or during sexual intercourse, the various taboos such as sexuality, menstruation and the female body, the discrediting of women’s words; the causes explained by religion as the suffering and punishment of original sin; sexist prejudices explaining the fact that women are less well cared for and under-diagnosed compared to men. We believe that raising awareness on the enhancement of women’s rights and gender equality should be encouraged to awaken women in our community. This would contribute to reducing the diagnostic delay in our environment.</p><p>QoL is a crucial concern for patients with endometriosis and practitioners and interventions should be tailored accordingly depending on each patient’s needs. In our series, the average EHP-5 score showed a severe deterioration in quality of life. To our knowledge, the current study is the first to evaluate QoL in patients with a validated questionnaire in a sub-Saharan population. We opt to use the EHP-5 questionnaire, a validated short version of the EHP-30 questionnaire exhibiting the same picture of health items but with less restrictive to complete [<xref ref-type="bibr" rid="scirp.125398-ref18">18</xref>] . Moreover, the simplicity and relevance of the EHP-5 questionnaire has been proven to assess the QoL of patients with endometriosis representing an adequate tool to assess the impact of medical and surgical management [<xref ref-type="bibr" rid="scirp.125398-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.125398-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.125398-ref20">20</xref>] . In addition, we demonstrated the relation between the degree of QoL alteration with some characteristics such as an inverse correlation with the age of the patients. Indeed, patients over 36 years old had a slight alteration compared to younger patients. Similarly, we observed that patients with history of labor had a lower impact on QoL. This agrees with a previous multicentric international study evaluating the QoL using SF-36 questionnaire in patients with colorectal endometriosis showing that patients with previous childbirth or without infertility had a better QoL, especially concerning the Mental Component Summary (MCS). On the other hand, we noted that women with a high socio-economic level presented a very severe alteration in the quality of life. this could be explained by the fact that these groups of patients have access to care because they have financial means, but unfortunately, they consulted several doctors who could not find a solution to their solution on the grounds that there was no precise diagnosis whereas these patients had signs suggestive of the disease so most of them were thrown into the beliefs that it was a curse. We must also emphasize that beyond the severity of the symptoms, it is important to consider all the epidemiological characteristics of the patients.</p><p>The EFI score was developed as a reproductive tool to predict the likelihood of spontaneous conception after surgery for infertile patients with endometriosis [<xref ref-type="bibr" rid="scirp.125398-ref20">20</xref>] - [<xref ref-type="bibr" rid="scirp.125398-ref24">24</xref>] . Our results go hand in hand with those found by Ferrier and collaborators, we all note that the EFI score 4 to 6 were the most found in our studies and this reinforces the orientation of infertile patients with endometriosis towards medically assisted procreation whose cost is already very high and less accessible in our environment not only for financial constraints but also and above all a lack of technical support for medically assisted procreation.</p><p>Some limitations of this study are worth highlighting. First, the retrospective nature of the study may be a source of bias. Patients’ answers regarding their quality of life before the procedure cannot be as precise as would be desirable, as it depends entirely on the patients’ recollection over a variable time scale. However, we believe this is offset by the fact that people with chronic pain, including endometriosis, usually live with their condition for long periods of time and therefore tend to have a clear idea of the nature of their symptoms. Second, the small sample size is also a potential bias. However, our goal was to have a homogeneous population with the diagnosis of endometriosis assessed not only on symptoms or imaging criteria but by systematic laparoscopy although Pascoal et al. pointed out that they found that the respective sensitivity and specificity of laparoscopy are 90% - 94% and 40% - 79% justifying, as in the current study, histological confirmation [<xref ref-type="bibr" rid="scirp.125398-ref25">25</xref>] . Finally, no attempt was made to evaluate the changes in QoL after operative laparoscopy while previous studies have reported on the relevance of QoL questionnaire post treatment to evaluate if patients had improvement in their quality of life after treatment [<xref ref-type="bibr" rid="scirp.125398-ref19">19</xref>] . Despite some limitations of the present study, its strength is that it will create a national awareness of the problems of endometriosis and therefore lead to system wide changes that will improve the care of women with endometriosis in sub-Saharan Africa.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Despite some limitations, our preliminary study highlights that in sub-Saharan Africa, the diagnosis of endometriosis is delayed and associated with a severe alteration in quality of life. Moreover, diagnosis of endometriosis seems to be restricted to women with high social levels. Therefore, further efforts are required to develop a health policy to decrease delay for diagnosis with potential benefits on symptoms, quality of life, fertility while limiting stigma and psychological effects of this debilitating pathology.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Sibo, M., Esimo, M., Lobota, M., Monka, I., Kayembe, K.K., Grace, T., Kevine, S., Patrick, M., Kabuya, N., Naomie, A., Fastrez, M., Ikoko, B., Ally, N., Georges, S., Berthe, B., Pita, M., Mbenza, L., Ferrier, C. and Darai, E. (2023) Diagnosis Delay and Assessment of the Quality of Life of Patients with Endometriosis Using the Endometriosis Health Profile 5 Questionnaire in a Sub-Saharan Population. Open Journal of Obstetrics and Gynecology, 13, 907-917. https://doi.org/10.4236/ojog.2023.135078</p></sec></body><back><ref-list><title>References</title><ref id="scirp.125398-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Zondervan, K.T., Becker, C.M., Koga, K., Missmer, S.A., Taylor, R.N. and Viganò, P. (2018) Endometriosis. Nature Reviews Disease Primers, 4, Article No. 9.  
https://doi.org/10.1038/s41572-018-0008-5</mixed-citation></ref><ref id="scirp.125398-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Gallagher, J.S., DiVasta, A.D., Vitonis, A.F., Sarda, V., Laufer, M.R. and Missmer, S.A. (2018) The Impact of Endometriosis on Quality of Life in Adolescents. Journal of Adolescent Health, 63, 766-772. https://doi.org/10.1016/j.jadohealth.2018.06.027</mixed-citation></ref><ref id="scirp.125398-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Nnoaham, K.E., Hummelshoj, L., Webster, P., et al. (2011) Impact of Endometriosis on Quality of Life and Work Productivity: A Multicenter Study across Ten Countries. Fertility and Sterility, 96, 366-373.  
https://doi.org/10.1016/j.fertnstert.2011.05.090</mixed-citation></ref><ref id="scirp.125398-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Stephen, K., Agneta, B., Charles, C., Thomas, D., Gerard, D., Robert, G., Hummelshoj, L., Prentice, A., Saridogan, E., on Behalf of the ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group (2005) ESHRE Guideline for the Diagnosis and Treatment of Endometriosis ESHRE Guideline for the Diagnosis and Treatment of Endometriosis. Human Reproduction, 20, 2698-2704. https://doi.org/10.1093/humrep/dei135</mixed-citation></ref><ref id="scirp.125398-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Simoens, S., Dunselman, G., Dirksen, C., et al. (2012) The Burden of Endometriosis: Costs and Quality of Life of Women with Endometriosis and Treated in Referral Centres. Human Reproduction, 27, 1290-1294.  
https://doi.org/10.1093/humrep/des073</mixed-citation></ref><ref id="scirp.125398-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Parazzini, F. (1999) Ablation of Lesions or No treatment in Minimal-Mild Endometriosis in Infertile Women: A Randomized Trial. Gruppo Italiano per lo Studio del l’Endometriosi. Human Reproduction, 14, 1332-1334.  
https://doi.org/10.1093/humrep/14.5.1332</mixed-citation></ref><ref id="scirp.125398-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Jacobson, T.Z., Barlow, D.H., Koninckx, P.R., Olive, D. and Farquhar, C. (2004) Laparoscopic Surgery for Subfertility Associated with Endometriosis. Cochrane Database of Systematic Reviews, No. 4, Article ID: CD001398.</mixed-citation></ref><ref id="scirp.125398-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Moore, J., Copley, S., Morris, J., Lindsell, D., Golding, S. and Kennedy, S. (2002) A Systematic Review of the Accuracy of Ultrasound in the Diagnosis of Endometriosis. Ultrasound in Obstetrics &amp; Gynecology, 20, 630-634.  
https://doi.org/10.1046/j.1469-0705.2002.00862.x</mixed-citation></ref><ref id="scirp.125398-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Prentice, A., Deary, A.J. and Bland, E. (2012) Progestagens and Anti-Progestagens for Pain Associated with Endometriosis. Cochrane Database of Systematic Reviews, No. 3, Article ID: CD002122.</mixed-citation></ref><ref id="scirp.125398-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Prentice, A., Deary, A.J., Goldbeck, W.S., Farquhar, C. and Smith, S.K., (2000) Gonadotrophin-Releasing Hormone Analogues for Pain Associated with Endometriosis. Cochrane Database of Systematic Reviews, No. 2, Article ID: CD000346.</mixed-citation></ref><ref id="scirp.125398-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Allen, C., Hopewell, S., Prentice, A. and Gregory, D. (2005) Non-Steroidal Anti-Inflammatory Drugs for Pain in Women with Endometriosis. Cochrane Database of Systematic Reviews, No. 4, Article ID: CD004753.  
https://doi.org/10.1002/14651858.CD004753.pub2</mixed-citation></ref><ref id="scirp.125398-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Enora, L., Marcos, B., Annie, C., Olivier, G. and Darai E. (2019) Unsupervised Clustering of Immunohistochemical Markers to Define High-Risk Endometrial Cancer. Pathology and Oncology Research, 25, 461-469.  
https://doi.org/10.1007/s12253-017-0335-y</mixed-citation></ref><ref id="scirp.125398-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Moore, J., Kennedy, S.H. and Prentice, A. (2000) Modern Combined Oral Contraceptives for Pain Associated with Endometriosis. Cochrane Database of Systematic Reviews, No. 2, Article ID: CD001019.</mixed-citation></ref><ref id="scirp.125398-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Dara&amp;#239;, E., Bazot, M., Ballester, M. and Belghiti, J. (2019) Endometriosis. La Revue du Praticien, 64, 545-550. (In French)</mixed-citation></ref><ref id="scirp.125398-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Dara&amp;#239;, E., Coutant, C., Bazot, M., Dubernard, G., Rouzier, R. and Ballester, M. (2009) Intérêt des questionnaires de qualité de vie chez les patientes porteuses d’une endométriose. Gynécologie Obstétrique &amp; Fertilité, 37, 240-245.  
https://doi.org/10.1016/j.gyobfe.2008.11.014</mixed-citation></ref><ref id="scirp.125398-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Laursen, B.S., Bajaj, P., Olesen, A.S., Delmar, C. and Arendt-Nielsen, L. (2005) Health Related Quality of Life and Quantitative Pain Measurement in Females with Chronic Non-Malignant Pain. European Journal of Pain, 9, 267.  
https://doi.org/10.1016/j.ejpain.2004.07.003</mixed-citation></ref><ref id="scirp.125398-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Fauconnier, A., Huchon, C., Chaillou, L., Aubry, G., Renouvel, F. and Panel, P. (2017) Development of a French Version of the Endometriosis Health Profile 5 (EHP-5): Cross-Cultural Adaptation and Psychometric Evaluation. Quality of Life Research, 26, 213-220. https://doi.org/10.1007/s11136-016-1346-y</mixed-citation></ref><ref id="scirp.125398-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Fritzer, N., Tammaa, A., Salzer, H. and Hudelist, G. (2014) Dyspareunia and Quality of Sex Life after Surgical Excision of Endometriosis: A Systematic Review. The European Journal of Obstetrics &amp; Gynecology and Reproductive Biology, 173, 1-6.  
https://doi.org/10.1016/j.ejogrb.2013.10.032</mixed-citation></ref><ref id="scirp.125398-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Dubernard, G., Piketty, M., Rouzier, R., Houry, S., Bazot, M. and Darai, E. (2006) Quality of Life after Laparoscopic Colorectal Resection for Endometriosis. Human Reproduction, 21, 1243-1247. https://doi.org/10.1093/humrep/dei491</mixed-citation></ref><ref id="scirp.125398-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Boujenah, J., Bonneau, C., Hugues, J.N., Sifer, C. and Poncelet, C. (2015) External Validation of the Endometriosis Fertility Index in a French Population. Fertility and Sterility, 104, 119-123. https://doi.org/10.1016/j.fertnstert.2015.03.028</mixed-citation></ref><ref id="scirp.125398-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Adamson, G.D. and Pasta, D.J. (2010) Endometriosis Fertility Index: The New, Validatedendometriosis Staging System. Fertility and Sterility, 94, 1609-1615.  
https://doi.org/10.1016/j.fertnstert.2009.09.035</mixed-citation></ref><ref id="scirp.125398-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Wang, W., Li, R., Fang, T., Huang, L., Ouyang, N., Wang, L., et al. (2013) Endometriosis Fertility Index Score Maybe More Accurate for Predicting the Outcomes of in Vitro Fertilisation than r-AFS Classification in Women with Endometriosis. Reproductive Biology and Endocrinology, 11, Article No. 112.  
https://doi.org/10.1186/1477-7827-11-112</mixed-citation></ref><ref id="scirp.125398-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Tomassetti, C., Geysenbergh, B., Meuleman, C., Timmerman, D., Fieuws, S. and D’Hooghe, T. (2013) External Validation of the Endometriosis Fertility Index (EFI) Staging System for Predicting Non-ART Pregnancy after Endometriosis Surgery. Human Reproduction, 28, 1280-1288. https://doi.org/10.1093/humrep/det017</mixed-citation></ref><ref id="scirp.125398-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Garavaglia, E., Pagliardini, L., Tandoi, I., Sigismondi, C., Viganò, P., Ferrari, S., et al. (2018) External Validation of the Endometriosis Fertility Index (EFI) for Predicting Spontaneous Pregnancy after Surgery: Further Considerations on Its Validity. Gynecologic and Obstetric Investigation, 79, 113-118.  
https://doi.org/10.1159/000366443</mixed-citation></ref><ref id="scirp.125398-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Pascoal, E., Wessels, J.M., Aas-Eng, M.K., Abrao, M.S., Condous, G., Jurkovic, D., Espada, M., et al. (2022) Strengths and Limitations of Diagnostic Tools for Endometriosis and Relevance in Diagnostic Test Accuracy Research. Ultrasound in Obstetrics &amp; Gynecology, 60, 309-327.</mixed-citation></ref></ref-list></back></article>